These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 36266542)

  • 1. Innate metabolic responses against viral infections.
    Palmer CS
    Nat Metab; 2022 Oct; 4(10):1245-1259. PubMed ID: 36266542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
    Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity.
    Loos C; Atyeo C; Fischinger S; Burke J; Slein MD; Streeck H; Lauffenburger D; Ryan ET; Charles RC; Alter G
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32878931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).
    Lotfi R; Kalmarzi RN; Roghani SA
    Immunol Res; 2021 Jun; 69(3):213-224. PubMed ID: 33928531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.
    Boechat JL; Chora I; Morais A; Delgado L
    Pulmonology; 2021; 27(5):423-437. PubMed ID: 33867315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2 Signaling Restricts SARS-CoV-2 Infection.
    Vanderheiden A; Thomas J; Soung AL; Davis-Gardner ME; Floyd K; Jin F; Cowan DA; Pellegrini K; Shi PY; Grakoui A; Klein RS; Bosinger SE; Kohlmeier JE; Menachery VD; Suthar MS
    mBio; 2021 Dec; 12(6):e0274921. PubMed ID: 34749524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated Innate Immune and Inflammatory Responses in SARS-CoV-2 Infection and COVID-19 Severity.
    Ghosh P; Nagaraja S; Basavaraju S; Kesavardhana S
    Crit Rev Immunol; 2021; 41(3):43-56. PubMed ID: 35378010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.
    Conti P; Younes A
    J Biol Regul Homeost Agents; 2020 March-April,; 34(2):339-343. PubMed ID: 32253888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulatory Effects of Physical Activity Levels on Immune Responses and General Clinical Functions in Adult Patients with Mild to Moderate SARS-CoV-2 Infections-A Protocol for an Observational Prospective Follow-Up Investigation: Fit-COVID-19 Study.
    Lira FS; Pereira T; Guerra Minuzzi L; Figueiredo C; Olean-Oliveira T; Figueira Freire APC; Coelho-E-Silva MJ; Caseiro A; Thomatieli-Santos RV; Dos Santos VR; Gobbo LA; Seelaender M; Krüger K; Pinho RA; Rosa-Neto JC; de Alencar Silva BS
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948858
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing Biomarkers in Viral Infection.
    Mayne ES; George JA; Louw S
    Adv Exp Med Biol; 2023; 1412():159-173. PubMed ID: 37378766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate Immune Responses to Acute Viral Infection During Pregnancy.
    Cornish EF; Filipovic I; Åsenius F; Williams DJ; McDonnell T
    Front Immunol; 2020; 11():572567. PubMed ID: 33101294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.
    Grolmusz VK; Bozsik A; Papp J; Patócs A
    Front Immunol; 2021; 12():653489. PubMed ID: 33763088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of coronavirus-19 disease.
    Borczuk AC; Yantiss RK
    J Biomed Sci; 2022 Oct; 29(1):87. PubMed ID: 36289507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
    Bouayad A
    Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.